This Week on NeurologyLive® — July 24, 2023
Here's some of what is coming soon to NeurologyLive® this week.
TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced
Neurology News Network for the week ending July 22, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — July 21, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 21, 2023.
This Week on NeurologyLive® — July 17, 2023
Polyunsaturated Fats and ALS Disease Progression, CAP-1002 Improves Motor Function in DMD, Lecanemab Granted Traditional Approval
Neurology News Network for the week ending July 15, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — July 14, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 14, 2023.
This Week on NeurologyLive® — July 10, 2023
Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function
Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — July 7, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending July 7, 2023.
This Week on NeurologyLive® — July 3, 2023
Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays
Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 30, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 30, 2023.
This Week on NeurologyLive® — June 26, 2023
CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine
Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 23, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 23, 2023.
This Week on NeurologyLive® — June 19, 2023
Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review
Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]
This Week on NeurologyLive® — June 12, 2023
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS
Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 9, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 9, 2023.
This Week on NeurologyLive® — June 5, 2023
CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule
Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — June 2, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending June 2, 2023.
This Week on NeurologyLive® — May 29, 2023
Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation
Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — May 26, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 26, 2023.
This Week on NeurologyLive® — May 22, 2023
Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD
Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — May 19, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 19, 2023.
This Week on NeurologyLive® — May 15, 2023